ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,700.30
-0.31%
S&P ASX All Technology
3,078.20
-0.47%
Brent Oil
82.795
0.82%
US Dollar vs AUD
1.51535
0.10%
Bitcoin
65,319.67
-1.98%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. NexGel Inc (NXGLW)

  7. NexGel Inc (NXGLW) News

NXGLW

NexGel (NXGLW)

NexGel Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NXGLW
DateTimeSourceHeadlineSymbolCompany
14/06/202407:19Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:NXGLWNexGel Inc
11/06/202422:40GlobeNewswire Inc.NEXGEL and STADA Partner to Launch Leading European DAO Enzyme Supplement, Histasolv, in North AmericaNASDAQ:NXGLWNexGel Inc
20/05/202420:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NXGLWNexGel Inc
16/05/202423:00GlobeNewswire Inc.NEXGEL Acquires International Beauty Brand, Silly GeorgeNASDAQ:NXGLWNexGel Inc
14/05/202407:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NXGLWNexGel Inc
14/05/202407:09Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NXGLWNexGel Inc
14/05/202406:05GlobeNewswire Inc.NEXGEL Reports First Quarter 2024 Revenue of $1.27 Million, an Increase of 104% Year-Over-YearNASDAQ:NXGLWNexGel Inc
09/05/202422:00GlobeNewswire Inc.NEXGEL to Report First Quarter 2024 Financial Results on May 13thNASDAQ:NXGLWNexGel Inc
07/05/202406:05GlobeNewswire Inc.NEXGEL to Present at the Aegis Capital Virtual Conference on May 9, 2024NASDAQ:NXGLWNexGel Inc
18/04/202422:00GlobeNewswire Inc.NEXGEL to Present at the Planet MicroCap Showcase: VEGAS 2024, May 1 & 2, 2024NASDAQ:NXGLWNexGel Inc
01/04/202422:50GlobeNewswire Inc.NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-YearNASDAQ:NXGLWNexGel Inc
28/03/202400:00GlobeNewswire Inc.NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to HolidayNASDAQ:NXGLWNexGel Inc
22/03/202400:00GlobeNewswire Inc.NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28thNASDAQ:NXGLWNexGel Inc
05/03/202400:30GlobeNewswire Inc.NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12thNASDAQ:NXGLWNexGel Inc
22/02/202408:05GlobeNewswire Inc.NEXGEL Announces $975,000 Registered Direct Offering Led by InsidersNASDAQ:NXGLWNexGel Inc
19/01/202401:00GlobeNewswire Inc.NEXGEL to Present at The Microcap Conference, January 30th through February 1stNASDAQ:NXGLWNexGel Inc
10/01/202400:30GlobeNewswire Inc.NEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024NASDAQ:NXGLWNexGel Inc
12/12/202300:00GlobeNewswire Inc.NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North AmericaNASDAQ:NXGLWNexGel Inc
06/12/202300:00GlobeNewswire Inc.NEXGEL Acquires Kenkoderm Psoriasis Skincare LineNASDAQ:NXGLWNexGel Inc
14/11/202308:05GlobeNewswire Inc.NEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-YearNASDAQ:NXGLWNexGel Inc
03/11/202300:00GlobeNewswire Inc.NEXGEL to Report Third Quarter 2023 Financial Results on November 13thNASDAQ:NXGLWNexGel Inc
30/10/202323:00GlobeNewswire Inc.NEXGEL Secures Supply Agreement with AbbVieNASDAQ:NXGLWNexGel Inc
26/09/202323:49GlobeNewswire Inc.NEXGEL to Participate in the LD Micro Main Event XVI on October 3rdNASDAQ:NXGLWNexGel Inc
15/08/202306:05GlobeNewswire Inc.NEXGEL Reports Second Quarter 2023 Record Revenue of $1.17 Million, an Increase of 108% Year-Over-YearNASDAQ:NXGLWNexGel Inc
02/08/202323:00GlobeNewswire Inc.NEXGEL to Report Second Quarter 2023 Financial Results on August 14thNASDAQ:NXGLWNexGel Inc
19/07/202323:10GlobeNewswire Inc.NEXGEL Partners with Enigma Health to Distribute its Leading Products in Retail Stores throughout North AmericaNASDAQ:NXGLWNexGel Inc
15/06/202323:00GlobeNewswire Inc.NEXGEL to Participate in Maxim Group’s Virtual Healthcare Conference on June 20thNASDAQ:NXGLWNexGel Inc
24/05/202323:00GlobeNewswire Inc.NEXGEL to Participate in the LD Micro Invitational XIII on June 6thNASDAQ:NXGLWNexGel Inc
16/05/202306:05GlobeNewswire Inc.NEXGEL Reports First Quarter 2023 Financial ResultsNASDAQ:NXGLWNexGel Inc
09/05/202323:15GlobeNewswire Inc.NEXGEL to Report First Quarter 2023 Financial Results on May 15thNASDAQ:NXGLWNexGel Inc
 Showing the most relevant articles for your search:NASDAQ:NXGLW

Your Recent History

FX
AUDUSD
AUD vs US Dollar
ASX
XTO
S&P ASX 100
ASX
XJO
S&P ASX 200
ASX
WBC
Westpac Banking
NASDAQ
AAPL
Apple
ASX
TLS
Telstra
ASX
XAO
Australian SE All Ordina...
ASX
BHP
BHP
ASX
WOW
Woolworths
ASX
SUN
Suncorp
ASX
XMM
S&P ASX 300 Metals and M...
CCOM
SILVER
SILVER
NASDAQ
MSFT
Microsoft
ASX
CSL
CSL
ASX
WES
Wesfarmers
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved